Digestive Diseases and Sciences

, Volume 59, Issue 12, pp 3027–3034 | Cite as

Ethnic Disparities in Gastric Cancer Incidence and Survival in the USA: An Updated Analysis of 1992–2009 SEER Data

  • Felix H. LuiEmail author
  • Bertrand Tuan
  • Sara L. Swenson
  • Robert J. Wong
Original Article



Gastric cancer (GC) is the second-leading cause of cancer-related deaths worldwide, with overall 5-year survival less than 20 %. However, limited data exist investigating ethnic disparities in stage-specific GC incidence and survival in the USA.


To evaluate ethnicity-specific differences in GC incidence and survival in the USA.


Using data from the surveillance, epidemiology, and end results 1992–2009 population-based cancer registry, we evaluated ethnic disparities in GC incidence stratified by year of diagnosis, cancer stage at presentation, and geographical distribution of disease. Ethnic disparities in survival were evaluated using Kaplan–Meier and multivariate Cox proportional hazards models.


Among men and women combined and among all cancer stages, Asians had the highest incidence of GC, more than double that among Whites (15.6 vs. 7.4 per 100,000/year, p < 0.005). In addition, Asians had the highest survival of all race groups (3-year survival: 26.6 %, p < 0.001). Compared with Whites, Blacks (12.8 vs. 7.4 per 100,000/year, p < 0.005) and Hispanics (12.9 vs. 7.4 per 100,000/year, p < 0.005) also had significantly higher incidence of GC. Multivariate Cox models (adjusted for age, year of diagnosis, sex, race/ethnicity, stage of disease, and treatment received) demonstrated significantly higher survival in Asians compared with Whites (HR 0.82, 95 % CI 0.80–0.85, p < 0.04).


Racial/ethnic disparities in GC incidence and survival exist in the USA Asians have the highest incidence of GC and the highest overall survival. Outlining high-risk groups may inform potential screening practices and physician awareness for GC.


Gastric adenocarcinoma Racial disparities Outcomes Epidemiology 



No funding was provided for this study.

Conflict of interest

The authors of this manuscript have no conflicts of interest to disclose as described by Digestive Diseases and Sciences.


  1. 1.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11.Google Scholar
  2. 2.
    Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.PubMedCrossRefGoogle Scholar
  3. 3.
    De Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin N Am. 2013;42:219–240.CrossRefGoogle Scholar
  4. 4.
    El-Serag HB, Mason AC, Petersen N, et al. Epidemiological differences between adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002;50:368–372.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Abrams JA, Gonsalves L, Neugut A. Diverging trends in the incidence of reflux-related and Helicobacter pylori-related gastric cardia cancer. J Clin Gastroent. 2013;47:322–327.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Devessa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053.CrossRefGoogle Scholar
  7. 7.
    Andeson WF, Camargo MC, Fraumeni JF Jr, et al. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303:1723.CrossRefGoogle Scholar
  8. 8.
    Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2004. Bethesda, MD: National Cancer Institute; 2007.Google Scholar
  9. 9.
    Surveillance, Epidemiology, and End Results (SEER) Program Pubic Use CD-ROM (1973-2009). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch.Google Scholar
  10. 10.
    Zhu AL, Sonnenberg A. Is gastric cancer again rising? J Clin Gastroenterol. 2012;46:804.PubMedCrossRefGoogle Scholar
  11. 11.
    Correa P. Gastric cancer: two epidemics? Dig Dis Sci. 2011;56:1585.PubMedCrossRefGoogle Scholar
  12. 12.
    Parkin DM, Bray F, Ferlay J, Pisani P. Global CA statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRefGoogle Scholar
  13. 13.
    Kim J, Sun CL, Mailey B, Prendergast C, et al. Race and ethnicity correlate with survival in patients with gastric cancer. Ann Oncol. 2010;21:152–160.PubMedCrossRefGoogle Scholar
  14. 14.
    Stressin AM, Sherr DL. Demographic disparities in patterns of care and survival outcomes for patients with resected gastric adenocarcinoma. Cancer Epidemiol Biomark Prev. 2011;20:223–233.CrossRefGoogle Scholar
  15. 15.
    Adachi Y, Kitano S, Sugimachi K. Surgery for gastric cancer: 10-year experience worldwide. Gastric Cancer. 2001;4:166–174.PubMedCrossRefGoogle Scholar
  16. 16.
    Pacelli F, Papa V, Caprino P, et al. Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors. Am Surg. 2001;67:697–703.PubMedGoogle Scholar
  17. 17.
    Gill S, Shah A, Le N, et al. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a Canadian cancer center. J Clin Oncol. 2003;21:2070–2076.PubMedCrossRefGoogle Scholar
  18. 18.
    Theuer CP, Kurosaki T, Ziogas A, et al. Asian patients with gastric carcinoma in the United States exhibit unique clinic features and superior overall and cancer specific survival rates. Cancer. 2000;89:1883–1892.PubMedCrossRefGoogle Scholar
  19. 19.
    Theuer CP. Asian gastric cancer patients at a southern California comprehensive cancer center are diagnosed with less advanced disease and have superior stage-stratified survival. Am Surg. 2000;66:821–826.PubMedGoogle Scholar
  20. 20.
    Lee JH, Ryu KW, Park SR. Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery. Ann Surg Oncol. 2006;13:1175–1181.PubMedCrossRefGoogle Scholar
  21. 21.
    Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–730.PubMedCrossRefGoogle Scholar
  22. 22.
    Al-Rafaie WB, Tseng JF, Gay G, et al. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Database. Cancer. 2008;113:461–469.CrossRefGoogle Scholar
  23. 23.
    Walker AR, Walker BF, Funani S, Segal I. Survival of black patients with gastric cancer in Soweto, Johannesburg, South Africa. Trop Gastroenterol. 1989;10:102–105.PubMedGoogle Scholar
  24. 24.
    Jinjuvadia R, Jinjuvadia K, Liangpunsakul S. Racial disparities in gastrointestinal cancers-related mortality in the US population. Dig Dis Sci. 2013;58:236–243.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Lhemelandu CU, DeWitty RL Jr, Leffall LD Jr, et al. Trends in clinicopathologic characteristics and prognostic predictors of survival outcome in black patients with gastric carcinoma: a single institution’s experience. J Surg Res. 2009;156:325–332.CrossRefGoogle Scholar
  26. 26.
    Brown R, Ponce NA, Rice T. The State of Health Insurance in California: Recent Trends, Future Prospects. Los Angeles, CA: UCLA Center for Health Policy Research; 2001.Google Scholar
  27. 27.
    Wu X, Chen VW, Andrews PA, Ruiz B, Correa P. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Causes Control. 2007;18:585–593.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Felix H. Lui
    • 1
    Email author
  • Bertrand Tuan
    • 2
  • Sara L. Swenson
    • 1
  • Robert J. Wong
    • 3
  1. 1.Department of Internal MedicineCalifornia Pacific Medical CenterSan FranciscoUSA
  2. 2.Department of Hematology/OncologyCalifornia Pacific Medical CenterSan FranciscoUSA
  3. 3.Division of Gastroenterology and HepatologyStanford University School of MedicineStanfordUSA

Personalised recommendations